Clinical Trial Educator program - A novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial

Clinical Trials

Volumn 9, Issue 3, 2012, Pages 358-366

  Kendall, Brigitte ^a   Städeli, Reto ^a   Schegg, Belinda ^a   Olbrich, Martin ^b   Chen, Edmond ^c   Harmelin Kadouri, Rona ^c   Aurup, Peter ^c   Schwab, Tilmann ^d   Hildemann, Steven K ^d  

^a Merck Sharp and Dohme Chibret AG   (Switzerland)

^b MSD Sharp and Dohme GmbH   (Germany)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL TRIAL EDUCATOR PROGRAM; COST EFFECTIVENESS ANALYSIS; EDUCATION PROGRAM; EPIDEMIOLOGY; EUROPE; GEOGRAPHY; HUMAN; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL (TOPIC); POST HOC ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ACUTE CORONARY SYNDROME; CLINICAL TRIALS, PHASE III AS TOPIC; EDUCATION; EUROPE; HUMANS; LACTONES; MULTICENTER STUDIES AS TOPIC; PATIENT SELECTION; PYRIDINES; RECEPTORS, THROMBIN; RESEARCH DESIGN; SAMPLE SIZE;

EID: 84862252603     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774512440760     Document Type: Article

References (24)

1. Cannon CP, Giugliano RP, Blazing MA, et al. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J 2008; 156: 826-32.
2. Giugliano RP, Newby LK, Harrington RA, et al. The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome - Study design and rationale. Am Heart J 2005; 149: 994-1002. (Pubitemid 40848143)
3. Giugliano RP, White JA, Bode C, et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med 2009; 360: 2176-90.
4. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: Literature summary and annotated bibliography. Control Clin Trials 1987; 8: 6S-30S.
5. Gul RB, Ali PA. Clinical trials: The challenge of recruitment and retention of participants. J Clin Nurs 2010; 19: 227-33.
6. Wright JR, Bouma S, Dayes I, et al. The importance of reporting patient recruitment details in phase III trials. J Clin Oncol 2006; 24: 843-45. (Pubitemid 46638833)
7. Hildemann SK, Bode C. Improving antiplatelet therapy for atherothrombotic disease: Preclinical results with SCH 530348, the first oral thrombin receptor antagonist selective for PAR-1. Hamostaseologie 2009; 29: 349-55.
8. Morrow DA, Scirica BM, Fox KA, et al. Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial. Am Heart J 2009; 158: 335-41.e3.
9. TRA*CER Executive and Steering Committees. The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: Study design and rationale. Am Heart J 2009; 158: 327-334.e4.
10. Francis D, Roberts I, Elbourne DR, et al. Marketing and clinical trials: A case study. Trials 2007; 8: 37.
11. Dyas JV, Apekey T, Tilling M, Siriwardena AN. Strategies for improving patient recruitment to focus groups in primary care: A case study reflective paper using an analytical framework. BMC Med Res Methodol 2009; 9: 65.
12. Thoma A, Farrokhyar F, McKnight L, Bhandari M. Practical tips for surgical research: How to optimize patient recruitment. Can J Surg 2010; 53: 205-10.
13. Butterfield PG, Yates SM, Rogers B, Healow JM. Overcoming subject recruitment challenges: Strategies for successful collaboration with novice research agencies. Appl Nurs Res 2003; 16: 46-52. (Pubitemid 38435374)
14. Lannin N, Cusick A. Factors affecting patient recruitment in an acute rehabilitation randomized controlled trial. Am J Occup Ther 2006; 60: 177-81. (Pubitemid 43516118)
15. Dugas M, Lange M, Berdel WE, Muller-Tidow C. Workflow to improve patient recruitment for clinical trials within hospital information systems - A case-study. Trials 2008; 9: 2.
16. Bowman SJ, Macfarlane GJ. Successful patient recruitment in investigator-led clinical trials. Rheumatology (Oxford) 2007; 46: 1207-08. (Pubitemid 47050629)
17. Haidich AB, Ioannidis JP. Determinants of patient recruitment in a multicenter clinical trials group: Trends, seasonality and the effect of large studies. BMC Med Res Methodol 2001; 1: 4.
18. Furimsky I, Cheung AH, Dewa CS, Zipursky RB. Strategies to enhance patient recruitment and retention in research involving patients with a first episode of mental illness. Contemp Clin Trials 2008; 29: 862-66.
19. Chang BH, Hendricks AM, Slawsky MT, Locastro JS. Patient recruitment to a randomized clinical trial of behavioral therapy for chronic heart failure. BMC Med Res Methodol 2004; 4: 8.
20. Dugas M, Lange M, Muller-Tidow C, Kirchhof P, Prokosch HU. Routine data from hospital information systems can support patient recruitment for clinical studies. Clin Trials 2010; 7: 183-89.
21. Garcia-Losa M, Dal-Re R, Garcia-Mendez E. Improving patient recruitment in clinical trials: Lessons from one multicentre study in asthma. Br J Clin Pharmacol 1995; 39: 211-12.
22. Heiney SP, Arp Adams S, Drake BF, et al. Successful subject recruitment for a prostate cancer behavioral intervention trial. Clin Trials 2010; 7: 411-17.
23. McDonald AM, Treweek S, Shakur H, et al. Using a business model approach and marketing techniques for recruitment to clinical trials. Trials 2011; 12: 74.
24. Lengacher CA, Gonzalez LL, Giuliano R, et al. The process of clinical trials: A model for successful clinical trial participation. Oncol Nurs Forum 2001; 28: 1115-20.